Why information alone is not enough: behavioral economics and the future of genomic medicine.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Behavioral Economics: A New Lens for Understanding Genomic Decision Making.Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 2018
   Article
2. Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.Expert review of molecular diagnostics · 2017
   Review
3. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.American journal of human genetics · 2016
   Article
4. The effect of genetic test-based risk information on behavioral outcomes: A critical examination of failed trials and a call to action.American journal of medical genetics. Part A · 2015
   Article

Corrections and comments

• Comment on
  Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial.2014

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as